NCT02153372View on ClinicalTrials.gov

Cell Therapy by Bone Marrow-derived Mononuclear Cells (BMC) for Large Bone Defect Repair: Phase-I Clinical Trial

PHASE1CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Humerus Fracture Displaced Proximal

Interventions

OTHER

BMC2012

Trial Locations (1)

60590

Department of trauma-, hand- and reconstructive surgery, Goethe University Hospital, Frankfurt

Sponsors

Lead Sponsor

Goethe University

All Listed Sponsors

collaborator

LOEWE CGT

UNKNOWN

lead

Goethe University

OTHER

NCT02153372 - Cell Therapy by Bone Marrow-derived Mononuclear Cells (BMC) for Large Bone Defect Repair: Phase-I Clinical Trial | Biotech Hunter | Biotech Hunter